Platelet aggregation and chlorpromazine therapy.
作者信息
Boullin D J, Know J M, Peters J R, Orr M W, Gelder M G, Grahame-Smith D G
出版信息
Br J Clin Pharmacol. 1978 Dec;6(6):538-40. doi: 10.1111/j.1365-2125.1978.tb00881.x.
Abstract
摘要
相似文献
1
Platelet aggregation and chlorpromazine therapy.血小板聚集与氯丙嗪治疗
Br J Clin Pharmacol. 1978 Dec;6(6):538-40. doi: 10.1111/j.1365-2125.1978.tb00881.x.
2
Increased platelet aggregation responses to 5-hydroxytryptamine in patients taking chlorpromazine.服用氯丙嗪的患者对5-羟色胺的血小板聚集反应增强。
Br J Clin Pharmacol. 1975 Feb;2(1):29-35. doi: 10.1111/j.1365-2125.1975.tb00468.x.
3
Human platelet function as a model for investigating the clinical efficacy of chlorpromazine.人体血小板功能作为研究氯丙嗪临床疗效的模型。
Br J Clin Pharmacol. 1981 Oct;12(4):535-42. doi: 10.1111/j.1365-2125.1981.tb01262.x.
4
Effects of aspirin and prostaglandin E2 on secondary phase aggregation responses of schizophrenic patients treated with chlorpromazine.阿司匹林和前列腺素E2对接受氯丙嗪治疗的精神分裂症患者继发相聚集反应的影响。
Br J Clin Pharmacol. 1976 Oct;3(5):929-33. doi: 10.1111/j.1365-2125.1976.tb00649.x.
5
The reliability of 5-hydroxytryptamine induced platelet aggregation responses in schizophrenic patients treated with neuroleptic drugs.使用抗精神病药物治疗的精神分裂症患者中5-羟色胺诱导的血小板聚集反应的可靠性。
Br J Clin Pharmacol. 1981 Mar;11(3):261-3. doi: 10.1111/j.1365-2125.1981.tb00531.x.
6
Resuspension of platelets: enhanced 5-hydroxytryptamine-induced aggregation in chlorpromazine treated patients due to changes in platelet properties.血小板再悬浮：由于血小板特性改变，氯丙嗪治疗的患者中5-羟色胺诱导的聚集增强。
Br J Clin Pharmacol. 1975 Feb;2(1):37-9. doi: 10.1111/j.1365-2125.1975.tb00469.x.
7
Proceedings: Cellular biochemical pharmacology in monitoring drug therapy.会议论文：细胞生化药理学在药物治疗监测中的应用
Arzneimittelforschung. 1976;26(6):1256-7.
8
The effects of neuroleptic drugs on 5-hydroxytryptamine induced platelet aggregation in schizophrenic patients.抗精神病药物对精神分裂症患者5-羟色胺诱导的血小板聚集的影响。
Br J Clin Pharmacol. 1981 Mar;11(3):255-9. doi: 10.1111/j.1365-2125.1981.tb00530.x.
9
Increased platelet aggregation in patients receiving chlorpromazine: responses to 5-hydroxytryptamine, dopamine and N-dimethyl dopamine.氯丙嗪治疗患者的血小板聚集增加：对 5-羟色胺、多巴胺和 N-二甲基多巴胺的反应。
Br J Clin Pharmacol. 1976 Aug;3(4):649-53. doi: 10.1111/j.1365-2125.1976.tb04889.x.
10
Serotonin receptor site in human platelets from control and chlorpromazine treated subjects.来自对照受试者和氯丙嗪治疗受试者的人血小板中的血清素受体位点。
Prog Biochem Pharmacol. 1980;16:119-32.
引用本文的文献
1
Antipsychotic-induced venous thromboembolism: a review of the evidence.抗精神病药物所致静脉血栓栓塞：证据综述
CNS Drugs. 2002;16(11):765-76. doi: 10.2165/00023210-200216110-00005.
2
Human platelet function as a model for investigating the clinical efficacy of chlorpromazine.人体血小板功能作为研究氯丙嗪临床疗效的模型。
Br J Clin Pharmacol. 1981 Oct;12(4):535-42. doi: 10.1111/j.1365-2125.1981.tb01262.x.
3
Platelet shape change in patients with psychiatric disorders and treated with phenothiazines, thioxanthines, butyrophenones, benzodiazepines, tricyclic antidepressants and beta-adrenergic blocking agents.患有精神疾病并接受吩噻嗪类、硫杂蒽类、丁酰苯类、苯二氮䓬类、三环类抗抑郁药和β-肾上腺素能阻滞剂治疗的患者的血小板形状变化。
J Neural Transm. 1981;51(3-4):245-56. doi: 10.1007/BF01248956.
4
The reliability of 5-hydroxytryptamine induced platelet aggregation responses in schizophrenic patients treated with neuroleptic drugs.使用抗精神病药物治疗的精神分裂症患者中5-羟色胺诱导的血小板聚集反应的可靠性。
Br J Clin Pharmacol. 1981 Mar;11(3):261-3. doi: 10.1111/j.1365-2125.1981.tb00531.x.
5
The effects of neuroleptic drugs on 5-hydroxytryptamine induced platelet aggregation in schizophrenic patients.抗精神病药物对精神分裂症患者5-羟色胺诱导的血小板聚集的影响。
Br J Clin Pharmacol. 1981 Mar;11(3):255-9. doi: 10.1111/j.1365-2125.1981.tb00530.x.
6
Assessment of anti-psychotic drugs.抗精神病药物的评估。
Br J Clin Pharmacol. 1981 Mar;11(3):225-36. doi: 10.1111/j.1365-2125.1981.tb00526.x.
7
Human platelet 5-hydroxytryptamine receptors: binding of [3H]-lysergic acid diethylamide (LSD). Effects of chronic neuroleptic and antidepressant drug administration.人血小板5-羟色胺受体：[3H] - 麦角酸二乙酰胺（LSD）的结合。长期给予抗精神病药和抗抑郁药的影响。
Experientia. 1988 Feb 15;44(2):142-5. doi: 10.1007/BF01952198.
8
Increased platelet membrane [3H]-LSD binding in patients on chronic neuroleptic treatment.长期接受抗精神病药物治疗的患者血小板膜[3H]-麦角酰二乙胺结合增加。
Br J Clin Pharmacol. 1985 Apr;19(4):453-7. doi: 10.1111/j.1365-2125.1985.tb02670.x.
本文引用的文献
1
The ralationship between changes in 5-HT induced platelet aggregation and clinical state in patients treated with fluphenazine.氟奋乃静治疗患者中5-羟色胺诱导的血小板聚集变化与临床状态之间的关系。
Br J Clin Pharmacol. 1976 Oct;3(5):925-8. doi: 10.1111/j.1365-2125.1976.tb00648.x.
2
The biochemical high-risk paradigm: behavioral and familial correlates of low platelet monoamine oxidase activity.生化高危范式：低血小板单胺氧化酶活性的行为及家族相关性
Science. 1976 Oct 15;194(4262):339-41. doi: 10.1126/science.968488.
3
Increased platelet aggregation responses to 5-hydroxytryptamine in patients taking chlorpromazine.服用氯丙嗪的患者对5-羟色胺的血小板聚集反应增强。
Br J Clin Pharmacol. 1975 Feb;2(1):29-35. doi: 10.1111/j.1365-2125.1975.tb00468.x.
4
5
Characterization of receptors mediating 5-hydroxytryptamine- and catecholamine-induced platelet aggregation, assessed by the actions of alpha- and beta-blockers, butyrophenones, 5-HT antagonists and chlorpromazine.通过α和β阻滞剂、丁酰苯类、5-羟色胺拮抗剂及氯丙嗪的作用评估介导5-羟色胺和儿茶酚胺诱导的血小板聚集的受体特性。
Br J Pharmacol. 1978 Apr;62(4):537-42. doi: 10.1111/j.1476-5381.1978.tb07758.x.
Zotero 插件